nationally accredited

Nov
11

Remdesivir Shows Promise in Largest of Several Clinical Trials

Remdesivir is a drug produced by Gilead Sciences for helping in treating Ebola patients. This antiviral drug has even experimented in the US clinical trials on around 1,063 coronavirus patients. When a patient suffering from the dreaded COVID-19 disease is hospitalized, he/she takes an average of 15 odd days to completely recover. When the same […]

DETAIL
Nov
10

Moderna’s Coronavirus Vaccine Spurs Immune Response: Early Data

As of 18th May 2020, drug maker Moderna, who were developing the SARS-CoV-2 vaccine announced that a candidate coronavirus vaccine test is successful and it can safely generate a considerable amount of immunity against the COVID-19 virus. This data was completely based on phase 1 of their clinical trials of the vaccine. According to reports, […]

DETAIL
Nov
04

SARS-CoV-2 Spike Protein Shares Sequence with a Human Protein

Medical science has already determined that there is a cleavage site in the COVID-19 spike protein for furin, which is also a human protease, and that spike unit is even subdivided into two different parts at that spot. This cleavage site helps in opening the virus such that it can easily enter a human cell. […]

By COVID Editor | Blog
DETAIL
Nov
02

COVID-19 Is “Very Different” in Young Kids Versus Adults

According to the World Health Organization or WHO, there are nearly ten million active COVID-19 cases all throughout the globe as of June 30, 2020. In the month of April, the United States Centers For Disease Control and Prevention reported that almost about two percent of the active coronavirus cases in the United States are […]

DETAIL